TrimRX
US$ 26.56
semaglutide compounding pharmacy ban Compounded Manufacturing States threaten to crack down
Description
Discover the top 2 oral peptides for muscle growth
Explore how the GLP-1 era is reshaping the food industry, driving demand for personalized nutrition, functional ingredients, and portion innovation.
GLP-1 weight loss drugs are transforming obesity treatment
Between 30 million and 50 million US adults could be taking a GLP-1 by 2034. In December 2024, 1.9 million prescriptions of GLP-1s to treat obesity (as opposed to diabetes, for example) were filled, nearly quadruple the number YoY, per IQVIA
